To address the increasing demand for medical professionals, the government has implemented several measures, including the establishment of new medical colleges by upgrading district and referral hospitals. A total of 131 out of 157 approved new medical colleges are already functional. Additionally, the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY) has seen approval for 75 projects aimed at upgrading government medical colleges, with 71 of those projects completed. The government has also approved 22 new AIIMS institutions, with undergraduate courses commencing in 19 of them. Initiatives like the Family Adoption Programme and the District Residency Programme have been introduced to enhance healthcare access in rural areas. Furthermore, non-monetary incentives, multi-skilling of doctors, and skill upgradation strategies under the National Rural Health Mission (NRHM) aim to address the shortage of specialists and improve overall health outcomes.

The post 13.86 Lakh Registered Allopathic Doctors, 7.51 Lakh Practitioners In AYUSH System: Centre appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.

The concerned Ayurvedic drug manufacturing company has been informed that such advertisements of drugs including Ayurvedic medicines are regulated under the provisions of Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder and the directives issued by the Central Government in the wake of COVID outbreak. Ministry had also issued a Gazette Notification No. L.11011/8/2020/AS dated 21st April, 2020 stating the requirements and the manner the research studies on COVID-19 with Ayush interventions/medicines should be undertaken.

In order to make this Ministry aware of the facts of the aforesaid news and verify the claims,  Patanjali Ayurved Ltd has been asked to provide at the earliest details of the name and composition of the medicines being claimed for COVID treatment; site(s)/hospital(s), where the research study was conducted for COVID-19; protocol, sample size, Institutional Ethics Committee clearance, CTRI registration  and results data of the study (ies) and stop advertising/publicizing such claims till the issue is duly examined. Ministry has also requested concerned State Licensing Authority of Uttrakhand Government to provide copies of license and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19.

The post Ayush stop claims of Patanjali Ayurved appeared first on newsmantra.in l Latest news on Politics, World, Bollywood, Sports, Delhi, Jammu & Kashmir, Trending news | News Mantra.